HVC_EriVan Bio_LOGO-01
EriVan revolutionizes the regenerative medicine space by delivering therapeutic mRNA and protein cargos via exosomes as natural targeted vehicles through partnerships with key external medical stakeholders. This practice improves the standard of care for certain treatments.

Pictured: co-founder Naseer Nassiri Koopaei. 

Points of Differientiation

Consistent and scalable manufacturing processes for multiple exosome types. EriVan Bio holds two patents, five trademarks and trade secrets for the exosome technology. Strategic and key partnerships with orthobiologics and neuroscience companies.

About Erivan Bio LLC

Hear from EriVan Bio LLC about their mission and what’s next on the horizon.

NYU Affiliation

Naseer Nassiri Koopaei, NYU BioLabs
Jahanara Ali, CAS Ph.D. ‘94
Brent Reynolds
Heshan Illangkoon
Scott Thomas

Contact Us

[email protected]

Learn More
Days :
Hours :
Minutes :
Seconds


See NYU's top startups
of Face off for $225K In Seed funding

NYU Entrepreneurs Challenge

Final Pitch Off & Awards

Friday, April 26th

Learn More